Arcutis Biotherapeutics Inc. (ARQT)
NASDAQ · Healthcare
Arcutis Biotherapeutics Inc. Shareholder Equity 2020–2025
Arcutis Biotherapeutics Inc. annual/quarterly shareholder equity history from 2020 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Arcutis Biotherapeutics Inc. shareholder equity for the quarter ending December 31, 2025 were 189.5M, a 20.27% increase year-over-year.
- Arcutis Biotherapeutics Inc. shareholder equity for 2025 were 189.5M, a 20.27% increase from 2024.
- Arcutis Biotherapeutics Inc. shareholder equity for 2024 were 157.5M, a 77.68% increase from 2023.
- Arcutis Biotherapeutics Inc. shareholder equity for 2023 were 88.7M, a 57.69% decrease from 2022.
- Arcutis Biotherapeutics Inc. shareholder equity for 2022 were 209.6M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Arcutis Biotherapeutics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $189 |
| 2024 | $158 |
| 2023 | $89 |
| 2022 | $210 |
| 2021 | $298 |
| 2020 | $271 |
| Arcutis Biotherapeutics Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $189 |
| 2024-12-31 | $158 |
| 2023-12-31 | $89 |
| 2022-12-31 | $210 |
| 2021-12-31 | $298 |
| 2020-12-31 | $271 |
Arcutis Biotherapeutics Inc. Shareholder Equity — FAQ
Arcutis Biotherapeutics Inc. (ARQT) shareholder equity over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ARQT's shareholder equity history?
The chart and table above show Arcutis Biotherapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.